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Aluminum phosphide (AlP) is used as pesticide in some countries for protection of stored
grains. Human poisoning with AlP due to suicide attempt or accidental environmental expo-
sure is associated with very high mortality partially due to development of severe metabolic
acidosis. Previous studies have shown that hemoglobin has high buffering capacity and
erythrocytes can potentially be used for management of metabolic acidosis. The aim of this
study was to evaluate the effect of fresh packed red blood cells (RBC) transfusion on sur-
vival and cardiovascular function in AlP-poisoned rats.
Methodology/Principal findings
Rats were poisoned with AlP by gavage. Fresh packed RBC was transfused via tail vein
after AlP administration. Acid-base balance, vital signs and mortality was assessed and
compared in experimental groups. Infusion of fresh packed RBC (1.5 ml) one hour after
AlP (4–15 mg/kg) intoxication was associated with a significant decrease in mortality rate.
Packed RBC infusion improved blood pH, HCO3-, Na+ and Ca2+ levels. Plasma troponin
level was also reduced and ECG changes were reversed following packed RBC infusion in
AlP intoxicated rats.
Conclusions
Our results showed that fresh RBC transfusion could ameliorate metabolic acidosis and
enhance survival in AlP-poisoned rat. We assume that an increase in pool of RBCs may
modulate acid-base balance or potentially chelate AlP-related toxic intermediates via phos-
phine-hemoglobin interaction.
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Introduction
Aluminum phosphide (AlP), also known as rice tablet, is used as pesticide in some countries
for protection of stored grains [1, 2]. Due to accidental exposure or suicide attempts, AlP
poisoning is still reported around the globe [3–6]. After exposure with moisture or gastric
hydrochloric acid, AlP is decomposed to form phosphine gas (PH3) which is a highly toxic
compound [7]. Several studies have shown that phosphine exerts severe deleterious effects on
biological systems. Singh et al. (2006) reported that phosphine interrupts mitochondrial oxida-
tive phosphorylation via inhibition of cytochrome-c oxidase which leads to anaerobic metabo-
lism, severe metabolic acidosis, multi-organ dysfunction and death [8]. Despite supportive
management and intensive care, most of intoxicated patient die following AlP ingestion as
there is no specific antidote for AlP poisoning. In 2001, Alter et al. reported a patient who
developed metabolic acidosis, progressive heart failure, hypotension and ventricular tachycar-
dia as a result of AlP ingestion [9]. Jaiswal et al. (2009) reported the importance of metabolic
acidosis in mortality of AlP by showing that correction of metabolic acidosis can increase
patients’ survival by 27% [10].
Due to the importance of metabolic acidosis in pathogenesis of AlP poisoning, the mainte-
nance of plasma pH seems to be a vital step in clinical management of patients with AlP
intoxication. Sodium bicarbonate can be administered to increase circulatory pH based on cal-
culation of base deficit [11]. However, severe metabolic acidosis in AlP-intoxicated patients
usually requires high doses of bicarbonate that are associated with side effects such as hyper-
capnia and sodium overload. Red blood cells (RBCs) are involved in extracellular acid-base
homeostasis. Hemoglobin has strong buffering capacity and erythrocytes anion-exchange
transporters facilitate the transport of ions across RBC membrane [12, 13]. These properties
enable RBCs to exhibit great capacity in maintaining blood pH in health (S1 Fig) and disease
[14–16]. In addition to modulation of pH, an increase in RBC number has the potential to che-
late phosphine gas via phosphine-hemoglobin interaction [17] and thus prevent inhibition of
mitochondrial respiratory chain and anaerobic metabolism. We hypothesize that an increase
in number of RBCs can prevent development of severe metabolic acidosis during AlP poison-
ing and the present study reports our investigations on the effect of RBC transfusion on sur-
vival, acid-base balance and cardiac function in a rat model of AlP intoxication.
Materials and methods
Animals
Wistar rats weighing 200–250 g (8-week-old) were obtained from Department of Pharmacol-
ogy, Tehran University of Medical Sciences. Animals were housed under standard laboratory
conditions in standard polycarbonate cages that included controlled ambient temperature
(23±1 ˚C), a 12-h-dark/12-h-light cycle, and free access to standard animal chow and water.
The study was conducted in accordance with the Guidelines for the Care and Use of Labo-
ratory Animal Ethics Committee of Tehran University of Medical Sciences as well as the
National Institutes of Health (NIH publication NO. 85–23; revised 1985). This study was regis-
tered and approved by the Tehran University of Medical Sciences Ethics committee (registra-
tion number: IR.TUMS.REC.1394.2119). Overall 22 experimental groups were used in this
study. Each rat was tested only once and each group consisted of 6–12 animals. All painful pro-
cedures including intravenous injection, placement of electrodes for ECG recording were per-
formed under general anesthesia using intraperitoneal injection of ketamine (85 mg/kg, i.p.)
and xylazine (15 mg/kg, i.p.). Animals were monitored continuously after administration of
AlP and their response to experimental interventions were logged every 30 min. All animals
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with severe respiratory distress (i.e. pronounced chest movement and gasping through the
mouth) were euthanized under carbon dioxide.
Chemicals
Chemicals were obtained from the following sources: aluminum phosphide (Samiran Pesticide
Formulating Co., Tehran, Iran), ketamine HCl (Gedoon Richter Ltd., Budapest, Hungary),
and xylazine HCl (Bayer AG, Leverkusen, Germany), sodium bicarbonate (Sterile solution,
Shahid Ghazi Pharmaceutical Co., Tabriz, Iran). All other reagents were purchased from
Merck (Germany). AlP pills were dissolved in almond oil (final volume 0. 6 ml) [18] and was
orally administered by a feeding needle (gavage). The same volume of vehicle (almond oil) was
used and orally administered to the control group.
Packed RBC preparation
For preparation of fresh packed RBC, blood was obtained from heart of intact deeply anesthe-
tized animals through heparinized syringes. Theses anesthetized rats were then sacrificed
using carbon dioxide. After performing cross-match, the obtained blood samples were centri-
fuged at 200 × g at room temperature for 10 min. Platelet rich plasma were separated, then
remained red cells were washed three times in isotonic saline (0.9% NaCl) using centrifugation
and re-suspending procedure. Following the last wash, packed cells (with hematocrit of 85%)
were separated and used as a fresh preparation for infusion via tail vein using an infusion
pump (Model 341B, Sage Instruments, Boston, Massachusetts) for 10 min at 37˚C.
Experimental protocol
A. Assessment of survival following fresh packed RBC transfusion in AlP poisoned
rats. Rats were randomized into different groups. Rats in separate groups received different
doses of AlP (4, 7, 12, 15, 21 mg/kg, orally using a feeding needle) then the mortality rate of
rats was assessed for 24 hours. Dose of 12 mg/kg was chosen for the next steps and the follow-
ing experiments were carried out to test the effect of packed RBC infusion on survival in poi-
soned rats. In all studies, at least 8 rats were used in each group.
Effect of time of packed RBC infusion on AlP-induced mortality: Packed RBC (1.5 ml)
was infused intravenously 30, 60, 90 and 120 min after oral administration of almond oil (as a
control group) or AlP (12 mg/kg) to determine the optimum time for RBC administration.
Effect of different volumes of infused packed RBC on AlP-induced mortality: Different
volume of packed RBC (0.5, 1 or 1.5 ml) was infused intravenously 60 min after oral adminis-
tration of almond oil (as a control group) or AlP (12 mg/kg) to find the optimized volume of
packed RBC infusion.
Effect of RBC infusion one hour after intoxication on LD50 of AlP: Animals infused with
packed RBC (1.5 ml) 1 hour after receiving different doses of oral AlP (4–21 mg/kg). The mor-
tality was assessed within 24 hours following AlP administration.
B. Effect of infused packed RBC on circulatory pH, electrolytes, troponin and ECG. A
separate group of animals were used in this section. Thirty minutes after almond oil or AlP
gavage (12 mg/kg), animals were anesthetized with intraperitoneal injection of ketamine (85
mg/kg, i.p.) and xylazine (15 mg/kg, i.p.), and placed on a heating pad to maintain body tem-
perature at 37˚C. Then, rats were connected to a bio-amplifier and a data acquisition system to
record ECG (PowerLab, ADInstruments, Australia). For ECG recording, needle electrodes
were inserted under the skin (lead II position). QRS complexes, PR segments, RR intervals,
QT intervals and ST segments were identified and calculated by Chart7 software (ADInstru-
ments, Australia). Blood samples were collected from the heart under anesthesia maximum
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five hours after almond oil or AlP administration. In case animals’ vital sign deteriorated
before five hours after AlP administration, blood samples were collected when rats exhibited
severe bradycardia and apnea. Blood pH, PCO2, electrolytes and troponin I levels were mea-
sured using routine methods.
C. Effect on bicarbonate administration on survival of AlP intoxicated rats. In a sepa-
rate group of animals, isotonic solution of sodium bicarbonate was injected in AlP-intoxicated
(12 mg/kg) or control rats and the survival was assessed within 24 hours. The amount of
bicarbonate was calculated from the “base deficit” of intoxicated animals using the formula
0.4 × body weight (kg) × base deficit (mM; which was estimated from previous experiment)
[11]. The calculated volume (~ 9 ml for an average rat) was injected i.p. in three hours with
rate of 3 ml/hour. The reason for i.p. injection was that calculate volume exceeded maximum
dose volume allowance for intravenous injection in rats.
Statistical analysis
Data are shown as the Mean ± S.E.M. Overall survival were assessed using Kaplan-Meier test
with log rank (Mantel-Cox) was used to determine the significance of mortality rate. One-way
analysis of variance (ANOVA) followed by Tukey or Bonferroni post hoc tests were performed
to determine the statistical significance of differences between the experimental means. Values
of P<0.05 were considered statistically significant. SPSS statistical software package (version
22) or GraphPad Prism (version 7.03) were used for statistical analysis.
Results
Effect of different doses of oral AlP on mortality in rats
Oral AlP administration showed very high mortality in rats. Doses higher than 7 mg/kg were
associated with 100% mortality within 24 hours. Fig 1 shows the Kaplan-Meier graph indicat-
ing a dose-dependent increase in mortality. Log-rank test showed that a highly significant
mortality at different doses of AlP (P<0.0001). 12 mg/kg was the lowest dose that could induce
100% mortality within 6 hours and this dose was chosen for the next steps of the present study.
Effect of delay time between AlP intoxication and packed RBC infusion on
mortality
Fresh packed RBC was infused intravenously 30, 60, 90 or 120 min after administration of
almond oil or AlP (12 mg/kg) in rats. As shown in Fig 2, infusion of packed RBC (1.5 ml) at
30, 60 and 90 minutes after AlP administration significantly decreased the mortality rate of
poisoned rats (P<0.001, P<0.001, P<0.001 respectively). Mortality rate of poisoned rats
decreased by infusion of fresh RBC 120 min after AlP administration but it was significantly
more than infusion at 30 and 60 minutes after AlP (P<0.05). None of almond oil treated rats
died during experiment.
Effect of different volumes of infused packed RBC on mortality of AlP-
intoxicated rats
Fig 3 illustrates the effect of intravenous administration of different volumes of packed RBC
(0.5, 1 and 1.5 ml.) on AlP-induced mortality within 4 hours after drug administration.
Administration of packed RBC (1 and 1.5 ml) significantly decreased the mortality rate of ani-
mals (P<0.01 and P<0.001) after injection. While, infusion of 0.5 ml packed RBC did not sig-
nificantly affect the mortality of animals.
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Effect of RBC infusion one hour after intoxication on LD50 of AlP
Fig 4 demonstrates dose-response curves for the toxic effect of AlP in two experimental set-
tings. Infusion of 1.5 ml packed RBC, one hour after AlP could double the LD50 of orally
administered AlP (6.7 mg/kg versus 14.1 mg/kg in AlP and AlP+RBC treated groups respec-
tively). Infusion of packed RBC was unable to decrease mortality when AlP dose was above 15
mg/kg.
Effect of infused packed RBC on heart rate and ECG parameters
Table 1 shows alterations in heart rate and ECG parameters within four hours in the experi-
mental groups. The following paragraphs summarized this Table:
Heart rate: Heart rate significantly decreased over time in AlP-treated rats and treatment with
packed RBC (1.5 ml) prevented development of bradycardia over 60–90 minutes in com-
parison to the AlP and significantly improved within 4 hours.
QT interval: QT interval was prolonged over 30–60 minutes in AlP groups in comparison with
control group and this change was continued after 60–90 minutes (P<0.001), while this
effect was significantly reversed in RBC-treated group.
ST segment: Administration of AlP caused a remarkable ST elevation in AlP-treated group
in comparison with the control group over 120–150 minutes (P<0.05). ST elevation was
significantly continued within 4 hours (P<0.001). Infusion of packed RBC significantly
reversed this effect as shown in Table 1.
Fig 1. Kaplan-Meier graph showing the survival rate of rats intoxicated with different doses of oral aluminum phosphide (AlP) within 24
hours.
https://doi.org/10.1371/journal.pone.0193991.g001
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QRS complexes: QRS widening was seen over 120–150 minutes after administration of AlP in
comparison to control group (P<0.05). This alteration was significantly continued in AlP-
treated rats after 150–180 minutes (P<0.001), whereas treatment with packed RBC infusion
significantly reversed these changes.
We also assessed development of arrhythmia in experimental rats after administration of
either AlP or vehicle (± RBC infusion). All almond oil treated rats had normal sinus rhythm
and did not show any evidence for development of ventricular ectopic beats or atrial fibrilla-
tion. On the other hand, all AlP treated rats exhibited development of atrial fibrillation starting
84 min (median, range: 76–100 min) after AlP administration. One AlP treated rats showed
development of multiple ventricular ectopic beats starting from 85 min post-AlP administra-
tion. AlP intoxicated rats that received fresh RBC infusion did not exhibit development of
atrial fibrillation or ventricular ectopic beats within 4 hours.
Effect of infused packed RBC on circulatory blood pH, PCO2, plasma
electrolytes, and troponin I
Table 2 indicates the effect of AlP (12 mg/kg) with or without packed RBC infusion on blood
pH, PCO2 and plasma bicarbonate and other electrolytes. A significant drop in blood pH was
observed in AlP group which was accompanied with a marked reduction in PCO2 and plasma
bicarbonate (i.e. consistent with development of metabolic acidosis). All aspects of metabolic
Fig 2. Effects of transfusions of fresh packed red blood cells (RBC) on mortality rate of aluminum phosphide
(AlP)-poisoned rats. Packed RBC (1.5 ml) was infused 30, 60, 90 and 120 min after oral administration of AlP (12 mg/
kg) and the mortality rate was assessed within 4 hours.  P<0.05,  P<0.001 compared to saline-treated group.
https://doi.org/10.1371/journal.pone.0193991.g002
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acidosis were prevented by infusion of 1.5 ml packed RBC as shown in Table 2. AlP poisoning
was also associated with low plasma Na+ (P<0.001) and Ca2+ (P<0.05) but the level of K+ did
not change significantly. Infusion of packed RBC (1.5 ml), one hour after AlP intake could sig-
nificantly reverse the changes observed in plasma Na+ and Ca2+ (Table 2). In addition to ST
elevation (demonstrated in Table 1), AlP administration could raise plasma troponin level sig-
nificantly (Table 2). Packed cell infusion could prevent both ST elevation and plasma troponin
concentrations (Table 2).
Effect on bicarbonate administration on survival of AlP intoxicated rats
Fig 5 shows the Kaplan-Meier graph indicating the effect of either saline or isotonic sodium
bicarbonate administration on mortality of AlP intoxicated rats. All AlP treated rats died
within 6 hours and sodium bicarbonate therapy could not prevent mortality (P = 0.39, Mantel-
Cox test, n = 8–10 in each group). Neither sodium bicarbonate-almond oil nor saline-almond
oil injections could induce any mortality as shown in Fig 5. We also collected blood samples
when rats exhibited vital signs deterioration (severe bradycardia and apnea). Sodium bicar-
bonate administration could markedly increase plasma bicarbonate concentration (8.4 ± 0.9
mM versus 28.8 ± 2.6 mM in AlP+Saline and AlP+Sodium-bicarbonate groups respectively,
P<0.001). However, sodium bicarbonate administration was unable to significantly increase
blood pH (6.94 ± 0.15 versus 7.24 ± 0.08 in AlP+Saline and AlP+Sodium-bicarbonate groups
respectively, P = 0.09). PCO2 showed a raise following sodium bicarbonate therapy in AlP poi-
soned rats and mean PCO2 was not significantly different from control rats (43.9 ± 3.6 mmHg
Fig 3. Effects of transfusions of different volumes of fresh packed red blood cells (RBC) on mortality rate of
aluminum phosphide (AlP)-poisoned rats. Packed RBC suspensions (0.5, 1 and 1.5 ml) were infused 60 min after
oral administration of AlP (12 mg/kg) and the mortality rate was assessed within 4 hours.  P<0.05,  P<0.01, 
P<0.001 compared to saline-treated group.
https://doi.org/10.1371/journal.pone.0193991.g003
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versus 50.1 ± 1.7 in AlP+Sodium-bicarbonate versus control group, P = 0.34). Analysis of ECG
in AlP+Sodium-bicarbonate group showed progressive bradycardia which was accompanied
with marked QT prolongation, QRS widening (data not shown).
Discussion
Aluminum phosphide is commonly used for protection of stored grains in Asian and African
countries. Because of its accessibility, it is used during suicide attempts in some countries such
as Iran and Morocco [4, 19]. In addition to its use as pesticide, AlP has application in semi-
conductor industry and accidental poisoning with AlP has been reported around the globe [3–
6]. The mortality of AlP poisoning is very high and clinicians often encounter difficulties in
management of severe metabolic acidosis in AlP-poisoned patients. Through the widespread
mortality rate of AlP intoxication, still its underlying mechanism is not well understood. It
appears that phosphine liberated from AlP in presence of water or gastric acid is responsible
for its toxic effects [7, 8, 9]. While, there is no effective known antidote for treatment of AlP;
supportive clinical management such as gastrointestinal lavage, intravenous infusion of crys-
talloids, bicarbonate, calcium gluconate, magnesium sulfate, vasopressors, glucose/insulin,
albumin and oxygen therapy are not sufficient to improve survival [7, 20, 21]. There are recent
case reports that indicate potential beneficial effects for new experimental therapies in treat-
ment of AlP poisoning but most of these reports are not randomized controlled trials and their
efficacy awaits further confirmation [22–28]. We hypothesized that infusion of packed RBC
may ameliorate metabolic acidosis, organ failure and mortality during AlP poisoning and our
hypothesis was rooted in the following previous reports: a. Hemoglobin has a high capacity in
buffering the proton (H+) and erythrocytes can modulate plasma pH via cooperation between
hemoglobin and membrane anion-exchange transporters [12, 13] and (S1 Fig). b. Hemogolbin
is a heme protein and can interact with phosphine gas [17,29]. Phosphine gas is liberated by
Fig 4. Dose-dependent motility curves for the toxic effect of aluminum phosphide (AlP) in rats with or without
transfusion of packed red blood cells (RBC). Packed RBC (1.5 ml) was infused one hour after oral administration of
different doses of AlP.
https://doi.org/10.1371/journal.pone.0193991.g004
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chemical decomposition of AlP in aqueous solution and is highly toxic due to inhibition of
mitochondrial heme proteins (e.g. cytochrome-c oxidase) and chelation of phosphine by
another heme protein may have potential benefit for the poisoned subjects. In this study, we
challenged poisoned rats with freshly prepared packed RBC and the results demonstrated a
positive effect in this rat model of AlP-induced intoxication. It appears that interaction of
phosphine with hemoglobin in poisoned patients may have implication in prediction of mor-
tality in AlP-intoxicated patients [30–32]. Mashayekhian et al., used non-invasive pulse CO-
oximetry in 96 patients with AlP poisoning and demonstrated that carbon monoxide satura-
tion was increased in these patients’ population [30]. Since this finding was not confirmed
Table 1. Effects of transfusions of fresh packed red blood cells (RBC) on heart rate (HR), and ECG parameters in three experimental groups.
Time (min) ECG parameter Control AlP AlP + RBC
0–30 HR (bpm) 336.33±5.77 318±7.27 318.5±16.95
QRS (ms) 0.016±0.0010 0.019±0.0036 0.015±0.00084
QT (ms) 0.067±0.0033 0.068±0.0043 0.070±0.0031
ST (mV) -0.031±0.0014 -0.015±0.039 -0.066±0.10
30–60 HR (bpm) 332.5±11.19 228.5±60.43 238±11.80
QRS (ms) 0.015±0.0010 0.018±0.0010 0.017±0.0020
QT(ms) 0.067±0.0013 0.076±0.0065 0.083±0.0010
ST (mV) -0.033±0.0037 -0.029±0.05 0.023±0.021
60–90 HR (bpm) 331.5±11.67 172.83±53.60 236.5±12.31#
QRS (ms) 0.017±0.00069 0.020±0.0031 0.017±0.0028
QT(ms) 0.073±0.0021 0.090±0.0072 0.075±0.00086###
ST (mV) -0.065±0.0025 -0.039±0.033 -0.024±0.020
90–120 HR (bpm) 330.83±10.00 168.5±22.77 260.33±9.065###
QRS (ms) 0.016±0.0010 0.022±0.0040 0.020±0.0017
QT (ms) 0.072±0.0023 0.10±0.0074 0.07±0.0037###
ST (mV) -0.042±0.015 -0.031±0.039 -0.064±0.032
120–150 HR (bpm) 334.16±11.15 142.83±17.34 275.16±12.01###
QRS (ms) 0.015±0.0010 0.020±0.0024 0.017±0.0023
QT (ms) 0.071±0.0034 0.094±0.0015 0.072±0.0037###
ST (mV) -0.038±0.012 +0.017±0.013 -0.096±0.039###
150–180 HR (bpm) 337.16±4.15 129.5±24.37 310.33±13.69###
QRS (ms) 0.017±0.00086 0.021±0.0017 0.016±0.0032#
QT (ms) 0.071±0.0031 0.10±0.0084 0.073±0.0025###
ST (mV) -0.05±0.015 +0.035±0.025 -0.062±0.031###
180–210 HR (bpm) 332.66±10.84 121.83±29.31 325±12.81###
QRS (ms) 0.016±0.00098 0.024±0.0026 0.017±0.0023###
QT (ms) 0.070±0.0033 0.11±0.0041 0.072±0.0023###
ST (mV) -0.044±0.015 0.030±0.010 -0.046±0.023###
210–240 HR (bpm) 337.66±12.44 98.3±10.31 333.25±10.55###
QRS (ms) 0.016±0.0041 0.034±0.002 0.016±0.0043###
QT (ms) 0.070±0.0013 0.12±0.004 0.070±0.003###
ST (mV) -0.038±0.02 +0.035±0.0162 -0.041±0.032###
 P < 0.05;
 P < 0.001 compared to control group;
# P < 0.05;
### P < 0.001 compared to AlP-treated group.
https://doi.org/10.1371/journal.pone.0193991.t001
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when tested by standard methods for carboxyhemoglobin measurement, they assumed that
hemoglobin was modified by phosphine to form a dyshemoglobin that interfered with pulse
CO-oximetry absorption spectra. Nevertheless, this artefactual increase in pulse CO-oximetry
signal was an independent predictor of mortality in AlP-intoxicated patients [30]. Another
clinical report demonstrated that two patients with G6PD (glucose-6 phosphate dehydroge-
nase) deficiency and extensive hemolysis, survived AlP poisoning despite having signs and
symptoms of fatal toxicity [32]. These reports are in line with a role for phosphine-hemoglobin
interaction in pathophysiology of AlP toxicity. Infusion of fresh RBC in AlP intoxicated rats














Control 7.38 ± 0.02 50.1 ± 1.7 21.01 ± 1.41 148.3 ± 2.7 4.8 ± 0.4 0.98 ± 0.08 0.03 ± 0.002
AlP 6.77 ± 0.06 40.8 ± 1.8 7.75 ± 1.53 139.0 ± 1.4 4.6 ± 0.5 0.88 ± 0.07 1.03 ± 0.02
AlP + RBC 7.33 ± 0.07### 47.7 ± 2.1# 20.5 ± 3.08### 147.1 ± 4.5### 4.9 ± 0.7 1.02 ± 0.07## 0.03 ± 0.003###
 P < 0.05;
 P < 0.01;
 P < 0.001 compared to control group;
# P < 0.05;
## P < 0.01;
### for P < 0.001 compared to AlP-treated group.
https://doi.org/10.1371/journal.pone.0193991.t002
Fig 5. Effect of sodium bicarbonate administration on mortality of aluminum phosphide (AlP) in rats. Kaplan-Meier graph
indicates the survival rate of rats intoxicated with AlP with concurrent administration of either isotonic sodium bicarbonate or
saline.
https://doi.org/10.1371/journal.pone.0193991.g005
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may modulate phosphine-hemoglobin interaction. However, further studies are required to
shed light on the mechanism of such modulation.
Our findings demonstrated that administration of fresh packed RBC significantly increased
survival rate and prevented development of severe metabolic acidosis in an experimental
model. Furthermore, packed RBC transfusion could ameliorate abnormal ECG changes (e.g.
ST elevation, QT prolongation and QRS widening) and severity of ventricular arrhythmia.
Also, the levels of troponin, plasma electrolytes such as Ca2+, Na+ were normalized following
administration of packed RBC. AlP induces acidosis and this leads to cardiac dysfunction, cir-
culatory failure and hypoxia [7, 19, 33]. Evolving data suggest that metabolic acidosis induces
negative inotropic and chronotropic effects and cardiac dysfunction [34]. RBC transfusion is
used in variety of clinical settings as a common treatment and intervention [35, 36]. Further-
more, some studies have shown that erythrocytes with high capacity of buffering can modulate
extracellular pH and decrease acidosis [12, 14]. Previous studies demonstrated that adminis-
tration of RBC can normalize pH and improves tissue oxygenation [12, 37, 38]. According to
our findings, packed RBC transfusion improved hemodynamic parameters in intoxicated rats.
Moreover, the results showed that electrophysiological parameters such as QT interval pro-
longation, ST elevation, QRS complex widening and development of arrhythmia were normal-
ized after administration of packed RBC in comparison with AlP group. This corroborates
with previous studies showing that RBC transfusion could decrease myocardial damage and
apoptosis in experimental models of myocardial infarction [15, 39].
Cardiac dysfunction and metabolic acidosis are major clinical symptoms in AlP poisoning
[40]. Our results showed that acute AlP intoxication induced low blood pH and low plasma
HCO3
- level which indicates development of metabolic acidosis in this rat model. We showed
that RBC transfusion could normalize pH and plasma Na+ and HCO3
- which corroborates
with improvement of acid-base balance in AlP poisoned rats. We also tested the effect of
sodium bicarbonate in our experimental model. Sodium bicarbonate therapy did not increase
survival in our model. Moreover, it was unable to restore acid-base balance in AlP poisoned
animals. In fact, the raise in pH was minimal and the pattern of changes in pH, plasma bicar-
bonate and PCO2 indicated a mixed acid-based imbalance following sodium bicarbonate ther-
apy in poisoned rats. Severe metabolic acidosis in AlP-treated rats was associated with a high
base deficit which required very high dose of sodium bicarbonate. Delivery of such high does
may be associated with complications such as sodium overload. We were unable to restore
metabolic acidosis with sodium bicarbonate therapy and this finding is in line with most clini-
cal reports for the existence of resistant metabolic acidosis during AlP poisoning [20]. After a
pilot study, we were surprised to observe that a simple intervention (fresh packed RBC infu-
sion) had such significant effect. The present study reports our investigations on the effect of
RBC transfusion on survival, metabolic acidosis and cardiac function in a rat model of AlP
intoxication. We have not explored the mechanism of this effect in present study. Future stud-
ies will pave the way to elucidate the protective mechanism of packed RBC infusion in AlP
intoxication.
We investigated the effect of different volumes of packed cells on survival. 0.5 ml packed
RBC was not enough to prevent mortality in this model and we observed that 1.5 ml could
markedly reduce mortality. An average rat with body mass of 300 g has ~19 ml blood [41] and
adding 1.5 ml leads to 7.3% increase in total blood volume. In terms of hematocrit, we can esti-
mate that adding 1.5 ml of packed RBC (with hematocrit of 85%) to 19 ml blood (with hemato-
crit of 42%) would increase the hematocrit to reach 45%. This means that infusion of 1.5
packed cell in our experimental model has the potential to increase the hematocrit by 3%. In
comparison with humans, it is known that one unit of packed cell (300 ml) can increase hemat-
ocrit to ~1.9% [42]. Therefore, the volume of packed cell administration in our experimental
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model is comparable with 1–2 units of packed RBC transfusion in an average human. Another
important issue for developing an antidote is knowing the maximum effective time lag between
poisoning and antidote administration. We assessed the effect of this time lag on mortality and
observed that packed RBC administration can be delayed until 60 min following AlP intoxica-
tion. A delay of 90 min from AlP gavage till RBC infusion was still effective in a small fraction
of intoxicated animals, but ~30% of rats could not survive when RBC was administered with
90 min delay. Although these results show the limitations of this approach in our experimental
setting, it can give a realistic view for the design of future clinical trials in humans. Neverthe-
less, this time-dependent effect predicts that patients who have been diagnosed early are more
likely to benefit from such intervention and fresh packed RBC infusion may not be helpful in
patients with delayed diagnosis of AlP intoxication. This may pose itself as a limitation for
implementation of this method in clinical settings. Another limitation of the present study is
that we followed up the experimental groups for 24 hours and only looked at the markers of
cardiac function. In addition to cardiac dysfunction, patients with AlP poisoning may suffer
from lung, hepatic and multiorgan failure which can complicate the prognosis and clinical
management of AlP intoxication. The effect of fresh packed RBC infusion on AlP-induced
multiorgan failure awaits further investigations.
Conclusion
We reported that administration of fresh packed RBC increases the rate of survival in rats
intoxicated with AlP. The mechanism of this protective effect is not known but we hypothesize
that a significant improvement in acid-base balance may play a role.
Supporting information
S1 Fig. The effect of erythrocytes on the buffering capacity of bicarbonate buffer in vitro.
To examine the effect of erythrocytes on the buffering capacity of bicarbonate buffer, fresh
erythrocytes were prepared and washed three times using isotonic 0.9% saline as described. 3
ml washed erythrocytes were added to 27 ml of either isotonic 0.9% NaCl solution or isotonic
physiological buffered solution containing 25 mM sodium bicarbonate. Isotonic HCl solution
was prepared by diluting HCl in NaCl solution to make a 10 mM isotonic HCl saline solution
(310 mOsmol/kg). A magnetic stirrer was used to study erythrocyte suspensions at room tem-
perature. Isotonic HCl solution was added to the erythrocyte suspensions with a constant rate
of 300 μl per 30 seconds and the changes in pH were measured using a digital pH meter (Met-
tler Toledo, USA). A separate set of erythrocyte-free physiological buffered solution (30 ml)
containing 25 mM bicarbonate was also used as control. Each experiment was repeated at least
3 times. The composition of bicarbonate physiological buffered solution in mM was as follows:
NaCl, 112; NaHCO3, 25; glucose, 10; KCl, 5; CaCl2, 1.8; MgCl2, 1; NaH2PO4, 0.5; KH2PO4, 0.5.
Data are expressed as mean ± S.E.M. As shown in S1Fig, both bicarbonate buffer and erythro-
cyte suspension (in normal saline) resisted against changes in pH induced by addition of HCl
in vitro. Addition of erythrocytes to bicarbonate buffer significantly enhanced the buffering
capacity of both milieus (Two-way ANOVA, P<0.001). This indicate that fresh erythrocytes
can markedly enhance the buffering capacity of bicarbonate-based physiological solutions.
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